Medical professionals may soon be able to detect bacteria in patient samples in minutes rather than days thanks to a new approach that traps and tests single cells, according to a team of biomedical engineers.
Currently, testing for pathogenic bacteria takes from three to five days, so physicians often treat patients initially with broad spectrum antibiotics rather than targeting specific microorganisms. They typically may not know whether the bacteria they are trying to kill are resistant to the antibiotics they might choose.
"Multidrug-resistant pathogens are common causes of patient morbidity and mortality," said the senior author. "Without a rapid method of microbiological analysis, physicians are often required to prescribe antibiotics empirically, using the worst-case assumption of the most severe bacteria."
The team created a device, using microchannels, that captures individual bacteria cells and lowers the microchannel ceiling until the bacterium is trapped. Microscopy can then determine the shape of the bacteria.
Because bacteria come in three main shapes -- spherical, rod-shaped, and spiral -- this step not only shows that bacteria are present in the sample but begins to classify them.
"Urinary tract infections are the most common bacterial infections," said the senior author. "However, over 75 percent of urine specimens sent to a clinical microbiology laboratory are negative. Rapidly ruling out or confirming the presence of bacteria at a clinically relevant concentration will dramatically enhance patient care."
After finding bacteria is present, the sample is exposed to antibiotics and the researchers then monitor bacterial growth. If the bacterium continues to grow after exposure, that strain is considered resistant to that antibiotic, but if the bacterium ceases to grow or dies, then the strain is not resistant, and the infection can be treated using a single, targeted antibiotic.
By monitoring their growth in the presence of antibiotics at the single-cell level, antimicrobial susceptibility of the bacteria can be determined in as little as 30 minutes compared with days required for standard procedures. The microfluidic system is able to detect bacterial pathogens in urine, blood cultures, and whole blood and can analyze polymicrobial samples.
The researchers report in a recent issue of the Proceedings of the National Academy of Sciences, that the combination of microchannel trapping and antibiotic exposure "rapidly determines the existence of bacteria, classifies major classes of bacteria, detects polymicrobial samples and identifies antimicrobial susceptibility directly from clinical samples at the single cell level."
The authors did a pilot study of 25 clinical urine samples to demonstrate the clinical applicability of the microfluidic system. The system is 100 percent sensitive to the presence of bacteria and will classify bacteria about an 83 percent of the time. It also achieved 100 percent agreement in identifying bacteria that are antibiotic resistant.
The adaptable, microchannel cell-trapping device is manufactured by molding, and according to the authors can be manufactured economically at production scale. They are currently working with GE Global Research to develop a benchtop version of the entire system for potential use in clinics, pharmacies, emergency rooms and physicians' offices. The microfluidic chip on which the analysis will be conducted will be disposable.
"This is similar to a printer and printer cartridges," said the senior author. "We are also exploring the feasibility of developing a portable or handheld version of the system for other applications, such as field testing, nursing homes and rural clinics." The researchers have a provisional patent.
https://news.psu.edu/story/572764/2019/05/06/research/rapid-bacterial-analysis-and-testing-antibiotic-sensitivity
https://www.pnas.org/content/early/2019/05/07/1819569116
Rapid bacterial analysis and testing for antibiotic sensitivity
- 912 views
- Added
Edited
Latest News
Antiaging effect of FGF21 in low protein diet
How antibiotics use can lead to fungal infection
Gene editing can alter the social behavior of animals
First successful treatment of mycobacterial lung infection with bacteriophages
Biomaterial improves islet transplants for treatment of type 1 diabetes
Other Top Stories
A near-universal way to measure enzyme inhibition
Lens-free fluorescent microscope
Allocating resources to synthetic circuits in bacteria may help drug production
Brain extracellular space imaging using SUSHI
Detecting molecular biomarker for osteoarthritis using nanotechnology
Protocols
Antibody structure prediction using interpretable deep learning
A semi-automated workflow for brain Slice Histology Alignment, Registration, and Cell Quantificat…
NanoDam identifies Homeobrain (ARX) and Scarecrow (NKX2.1) as conserved temporal factors in the D…
Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays
Integrating neuroimaging and gene expression data using the imaging transcriptomics toolbox
Publications
FGF21 is required for protein restriction to extend lifespan and improve metabolic health in male…
Spreading depolarizations in ischaemia after subarachnoid haemorrhage, a diagnostic phase III study
CRISPR-Cas9 editing of the arginine-vasopressin V1a receptor produces paradoxical changes in soci…
Mitochondrial LETM1 drives ionic and molecular clock rhythms in circadian pacemaker neurons
Ca2+ signals in plant immunity
Presentations
Hydrogels in Drug Delivery
Lipids
Cell biology of carbohydrate metabolism
RNA interference (RNAi)
RNA structure and functions
Posters
ASCO-2020-HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT
ASCO-2020-HEAD AND NECK CANCER
ASCO-2020-GENITOURINARY CANCER–KIDNEY AND BLADDER
ASCO-2020-GENITOURINARY CANCER–PROSTATE, TESTICULAR, AND PENILE
ASCO-2020-GYNECOLOGIC CANCER